Highlights Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 05/12/2025 GMT			5-day change	1st Jan Change
2,032.00 ^DKK	-1.45%		-0.34%	+36.15%

12-04	Genmab A/S Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09:45 AM
12-04	Genmab Closes $2.5 Billion Senior Notes Offering	MT

Highlights

Genmab A/S and Genmab Finance LLC Announces Closing of Private Offering of Senior Secured Notes and Senior Unsecured Notes	12-03	CI
Genmab, Pfizer's Cervical Cancer Drug Gets UK Regulatory Nod	12-02	MT
Genmab's Cervical Cancer Drug Gets UK Regulatory Approval	12-02	MT
Genmab Secures US Approval for Follicular Lymphoma Combo Therapy	11-18	MT
Genmab A/S Announces EPKINLY (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma	11-18	CI
Fitch Assigns First-time Rating to Genmab with Stable Outlook	11-11	MT
Genmab Plans $2.5 Billion Notes Offering, Launches Syndication of $2 Billion Term Loan	11-10	MT
Genmab announces proposed private offerings	11-10	RE
Genmab advances on earnings strength and pipeline while lower valuation opens upside	11-07
Genmab A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	11-06	CI
Genmab's Q3 Net Profit, Revenue Increase; 2025 Revenue Outlook Maintained	11-06	MT
Genmab Provides Earnings Guidance for the Full Year 2025	11-06	CI
Genmab says nine months revenue increases 21% to $2,662 million	11-06	RE
Genmab Commences $8 Billion Takeover Offer for Merus	10-21	MT
Genmab A/S Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®?) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer	10-18	CI
Aktiespararna Recommends Buying Genmab Shares	10-17	FW
EQT Is Shareholder in Merus, Acquired by Denmark's Genmab	09-30	FW
EQT sells portfolio company Merus to Genmab for $8 billion	09-30	FW
Sector Update: Health Care Stocks Edge Lower Monday Afternoon	09-29	MT
Top Midday Stories: Electronic Arts Going Private in $55 Billion Deal; Genmab to Acquire Merus for $8 Billion	09-29	MT
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says	09-29	MT
Sector Update: Health Care Stocks Rise Premarket Monday	09-29	MT
Sector Update: Health Care	09-29	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Trump, Democrats Meeting	09-29	MT
Genmab Agrees to Acquire Merus for $8 Billion	09-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab advances on earnings strength and pipeline while lower valuation opens upside

November 07, 2025 at 03:01 pm

Genmab: From now on, courage to the most patient

April 01, 2025 at 03:57 pm